Treatment of refractory uveitis with adalimumab: A prospective multicenter study of 131 patients

Ophthalmology

Volumn 119, Issue 8, 2012, Pages 1575-1581

  Díaz Llopis, Manuel ^a,l   Salom, David ^a   Garcia De Vicuña, Carmen ^b   Cordero Coma, Miguel ^c   Ortega, Gabriela ^d   Ortego, Norberto ^e   Suarez De Figueroa, Marta ^f   Rio Pardo, Maria J ^g   Fernandez Cid, Carlos ^h   Fonollosa, Alex ⁱ   Blanco, Ricardo ^j   Garcia Aparicio, Angel M ^k   Benitez Del Castillo, Jose M ^l   Olea, Jose L ^m   Arevalo, J Fernando ^n,o,p  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c HOSPITAL DE LEÓN   (Spain)

^d INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h Hospital de Pontevedra   (Spain)

ⁱ HOSPITAL DE CRUCES   (Spain)

^j HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^k HOSPITAL VIRGEN DE LA SALUD   (Spain)

^l HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^m HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

ⁿ Clinica Oftalmologica Centro Caracas   (Venezuela)

^o JOHNS HOPKINS UNIVERSITY   (United States)

^p KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; PREDNISONE;

ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ANTERIOR EYE CHAMBER; ARTHRITIS; ARTICLE; BEHCET DISEASE; CASE STUDY; CHILD; CHORIORETINOPATHY; CHOROIDITIS; CLINICAL EVALUATION; COGAN SYNDROME; CROHN DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTERMEDIATE UVEITIS; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; POSTERIOR EYE CHAMBER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; RELAPSE; RETINA MACULA LUTEA; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCHOOL CHILD; SJOEGREN SYNDROME; STEROID THERAPY; SYMPATHETIC OPHTHALMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITREOUS BODY; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, SUBCUTANEOUS; MACULA LUTEA; MALE; METHOTREXATE; OFF-LABEL USE; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; VISUAL ACUITY;

EID: 84864466773     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.02.018     Document Type: Article

References (32)

1. R.L. Smit, G.S. Baarsma Epidemiology of uveitis Curr Opin Ophthalmol 6 1995 57 61
2. J.H. Chang, D. Wakefield Uveitis: a global perspective Ocul Immunol Inflamm 10 2002 263 279
3. D.C. Gritz, I.G. Wong Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study Ophthalmology 111 2004 491 500
4. M.S. Suttorp-Schulten, A. Rothova The possible impact of uveitis in blindness: a literature survey Br J Ophthalmol 80 1996 844 848
5. A. Rothova, H.J. Buitenhuis, C. Meenken Uveitis and systemic disease Br J Ophthalmol 76 1992 137 141
6. S. Lightman, H. Towler Immunopathology and altered immunity in posterior uveitis in man: a review Curr Eye Res 11 Suppl 1992 11 15
7. M.D. Becker, G. Adamus, M.P. Davey, J.T. Rosenbaum The role of T cells in autoimmune uveitis Ocul Immunol Inflamm 8 2000 93 100
8. S.R. Taylor, H. Isa, L. Joshi, S. Lightman New developments in corticosteroid therapy for uveitis Ophthalmologica 224 Suppl 2010 46 53
9. P.I. Murray, R.R. Sivaraj Anti-TNF-alpha therapy for uveitis: Behçet and beyond Eye (Lond) 19 2005 831 838
10. M. Santos Lacomba, C. Marcos Martín, J.M. Gallardo Galera Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis Ophthalmic Res 33 2001 251 255
11. V. Pérez-Guijo, M. Santos-Lacomba, M. Sánchez- Hernández Tumour necrosis factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27 Curr Med Res Opin 20 2004 155 157
12. C.E. Rabinovich Use of tumor necrosis factor inhibitors in uveitis Curr Opin Rheumatol 19 2007 482 486
13. F.R. Imrie, A.D. Dick Biologics in the treatment of uveitis Curr Opin Ophthalmol 18 2007 481 486
14. P. Neri, M. Zucchi, P. Allegri Adalimumab (Humira): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology Int Ophthalmol 31 2011 165 173
15. M. Rudwaleit, E. Rodevand, P. Holck Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study Ann Rheum Dis 68 2009 696 701
16. A.M. Mansour Adalimumab in the therapy of uveitis in childhood Br J Ophthalmol 91 2007 274 276
17. S. Biester, C. Deuter, H. Michels Adalimumab in the therapy of uveitis in childhood Br J Ophthalmol 91 2007 319 324
18. G. Simonini, A. Taddio, M. Cattalini Prevention of flare recurrences in childhood refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab Arthitis Care Res (Hoboken) 63 2011 612 618
19. K. Takase, S. Ohno, H. Ideguchi Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis Rheumatol Int 31 2011 243 245
20. M. Díaz-Llopis, S. García-Delpech, D. Salom Adalimumab therapy for refractory uveitis: a pilot study J Ocul Pharmacol Ther 24 2008 351 361
21. Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data Results of the first international workshop Am J Ophthalmol 140 2005 509 516
22. R.B. Nussenblatt, A.G. Palestine, C.C. Chan Standardization of vitreal inflammatory activity in intermediate and posterior uveitis Ophthalmology 92 1985 467 471
23. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study (AREDS): design, implications AREDS report no. 1 Control Clin Trials 20 1999 573 600
24. G.J. Jaffe, D. Martin, D. Callanan Fluocinolone Acetonide Uveitis Study Group Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study Ophthalmology 113 2006 1020 1027
25. R.B. Nussenblatt, J.S. Peterson, C.S. Foster Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series Ophthalmology 112 2005 764 770
26. J. Deschenes, P.I. Murray, N.A. Rao, R.B. Nussenblatt International Uveitis Study Group (IUSG) clinical classification of uveitis Ocul Immunol Inflamm 16 2008 1 2
27. J.L. Callejas-Rubio, D. Sánchez-Cano, J.L. García Serrano, N. Ortego-Centeno Adalimumab therapy for refractory uveitis: a pilot study [letter] J Ocul Pharmacol Ther 24 2008 613 614 author reply 614
28. I.K. Petropoulos, J.D. Vaudaux, Y. Guex-Crosier Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of the Jules Gonin Eye Hospital Klin Monbl Augenheilkd 225 2008 457 461
29. L.B. Vazquez-Cobian, T. Flynn, T.J. Lehman Adalimumab therapy for childhood uveitis J Pediatr 149 2006 572 575
30. P. Tynjälä, K. Kotaniemi, P. Lindahl Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis Rheumatology (Oxford) 47 2008 339 344
31. B. Mushtaq, T. Saeed, R.D. Situnayake, P.I. Murray Adalimumab for sight-threatening uveitis in Behçet's disease Eye (Lond) 21 2007 824 825
32. S. Guignard, L. Gossec, C. Salliot Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondyloarthropathy: a retrospective study Ann Rheum Dis 65 2006 1631 1634